Therapeutics: Protein kinase C α (PRKCA); β amyloid (Aβ)

Neurology

INDICATION: Alzheimer's disease (AD)

Patient sample and mouse studies suggest inhibiting PRKCA could

Read the full 125 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE